Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|March 9, 2016
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialJonathan E Rosenberg, Jean Hoffman-Censits, Tom Powles, et al.
Nature Medicine|February 14, 2012
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsiesDoron Lipson, Marzia Capelletti, Roman Yelensky, et al.
Cancer Cell|October 8, 2019
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 ActivityJacqulyne P Robichaux, Yasir Y Elamin, R S K Vijayan, et al.
The Journal of Molecular Diagnostics : JMD|June 25, 2018
Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNATravis A Clark, Jon H Chung, Mark Kennedy, et al.
The Oncologist|June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ HybridizationSiraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Cancer Discovery|May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitorsGarrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
The Oncologist|October 13, 2019
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRAUmut Disel, Russell Madison, Kumar Abhishek, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Nature Biotechnology|October 22, 2013
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencingGarrett M Frampton, Alex Fichtenholtz, Geoff A Otto, et al.
Neuro-Oncology|July 12, 2023
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A Williams, Ajay Ravindranathan, Rohit Gupta, et al.
Pageof 13